- “US FDA staff question King imaging drug results” (Reuters)
- “Regeneron gets $20M milestone from Bayer” (FierceBiotech)
- “Teva, J&J settle oral contraceptive patent case” (Reuters)
- “EU drugs agency recommends Novartis’ Ilaris” (Reuters)
- “The Obama biotech boost” (CNNMoney.com)
- “Drugmaker Wyeth posts 13 percent jump in 2Q profit” (The Associated Press)
- “AstraZeneca to tweak prescription savings plan” (The News Journal)
- “Strong sales boost Bristol-Myers 2Q profit” (The Associated Press)
- “Bristol-Myers, Wyeth turn in strong 2Q results” (The Associated Press)
- “Teva and Ortho-McNeil-Janssen Settle Ortho Tri-Cyclen® Lo Litigation” (Press release issued by Teva Pharmaceuticals, Business Wire)
- “Merck KGaA Falls; EU Rejects Erbitux for Lung Cancer” (Bloomberg)
- “Aurobindo Pharma Gets FDA OK For Zidovudine Tablets” (Wall Street Journal)
- “EU Panel OKs Pandemic Influenza Vaccine H5N1 From Glaxo” (Wall Street Journal)
- “Merck reports proposed settlement of litigation” (MarketWatch)
- “Pfizer Faces First Trial on Claim Neurontin Boosts Suicide Risk” (Bloomberg)
THE LATEST WORD
Top Industry Stories – July 24, 2009
Posted on July 24th, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
Careers | © 2009 Medical Dynamics